KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Sarepta Therapeutics (SRPT) over the last 13 years, with Q2 2025 value amounting to 0.11%.

  • Sarepta Therapeutics' Return on Capital Employed rose 1000.0% to 0.11% in Q2 2025 from the same period last year, while for Jun 2025 it was 0.11%, marking a year-over-year increase of 1000.0%. This contributed to the annual value of 0.08% for FY2024, which is 1800.0% up from last year.
  • Latest data reveals that Sarepta Therapeutics reported Return on Capital Employed of 0.11% as of Q2 2025, which was up 1000.0% from 0.07% recorded in Q4 2024.
  • In the past 5 years, Sarepta Therapeutics' Return on Capital Employed ranged from a high of 0.11% in Q2 2025 and a low of 0.27% during Q2 2021
  • For the 5-year period, Sarepta Therapeutics' Return on Capital Employed averaged around 0.13%, with its median value being 0.18% (2022).
  • Its Return on Capital Employed has fluctuated over the past 5 years, first crashed by -800bps in 2023, then surged by 2100bps in 2024.
  • Over the past 5 years, Sarepta Therapeutics' Return on Capital Employed (Quarter) stood at 0.19% in 2021, then dropped by -13bps to 0.21% in 2022, then skyrocketed by 50bps to 0.11% in 2023, then surged by 168bps to 0.07% in 2024, then soared by 58bps to 0.11% in 2025.
  • Its Return on Capital Employed was 0.11% in Q2 2025, compared to 0.07% in Q4 2024 and 0.03% in Q3 2024.